+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


European Respiratory Device Market 2019-2025

  • ID: 5013453
  • Report
  • February 2020
  • Region: Europe
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now


  • 3M Co.
  • Adherium Ltd.
  • AstraZeneca PLC
  • Gilbert Technologies B.V.
  • Hamilton Medical AG
  • Medtronic PLC
  • MORE
European Respiratory Device Market Size, Share & Trends Analysis Report by Product (Therapeutic Devices, Diagnostic and Monitoring Devices, and Consumables and Accessories), by End-User (Homecare and Hospitals and Clinics) and Forecast 2019-2025.

The European respiratory device market was valued at around $5.8 billion in 2018 and is estimated to grow at a CAGR of around 5.8% during the forecast period. Major countries that contribute to the regional respiratory device market include UK, Germany, France, Italy, and Spain. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in Europe. The increasing demand from chronic obstructive pulmonary disease (COPD), Sleep Apnea and asthma patients in the major economies of the region is favoring the growth of the regional market.

The European respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the regional market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include ResMed Corp., Chiesi Farmaceutici S.P.A., GlaxoSmithKline PLC, 3M Co., Novartis AG, Teicos Pharma Ltd., and others. The market players are adopting the strategy of merger & acquisition, product launch and expansion of their manufacturing facilities to increase their market share. For instance, in September 2017, Chiesi Farmaceutici completed the clinical study of Tribute with its Trimbow an extra-fine fixed-dose triple combination inhaler. The organization also got the marketing authorization for Trimbow from the European Commission. In November 2016, the company acquired Atopix therapeutics limited, the transaction aimed to develop novel treatments for asthma and strengthen the company’s asthma portfolio.

Research Methodology

The market study of the European respiratory device market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for respiratory device manufacturers, contract research organizations (CROs), the healthcare sector, market research firms, and government organizations, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. European Respiratory Device Market Research and Analysis by Product
2. European Respiratory Device Market Research and Analysis by End-User

The Report Covers:
  • Comprehensive research methodology of the European respiratory device market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the European respiratory device market.
  • Insights about market determinants which are stimulating the European respiratory device market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • 3M Co.
  • Adherium Ltd.
  • AstraZeneca PLC
  • Gilbert Technologies B.V.
  • Hamilton Medical AG
  • Medtronic PLC
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. European Respiratory Device Market by Product
5.1.1. Therapeutic Devices
5.1.2. Diagnostic and Monitoring Devices
5.1.3. Consumable and Accessories
5.2. European Respiratory Device Market by End-User
5.2.1. Homecare
5.2.2. Hospitals and Clinics

6. Regional Analysis
6.1. UK
6.2. Germany
6.3. France
6.4. Italy
6.5. Spain
6.6. Rest of Europe

7. Company Profiles
7.1. 3M Co.
7.2. Acorda Therapeutics, Inc.
7.3. Adamis Pharmaceuticals Corp.
7.4. Adherium Ltd.
7.5. Air Liquide S.A.
7.6. AstraZeneca PLC
7.7. Bespak
7.8. Boehringer Ingelheim International GmbH
7.9. Chiesi Farmaceutici S.P.A.
7.10. Gilbert Technologies B.V.
7.11. GlaxoSmithKline PLC
7.12. H&T Presspart Manufacturing Ltd.
7.13. Hamilton Medical AG
7.14. Koninklijke Philips N.V.
7.15. Medtronic PLC
7.16. Novartis AG
7.17. PMD Device Solutions Ltd.
7.18. ResMed Corp.
7.19. Savara, Inc.
7.20. Teicos Pharma Ltd.
7.21. Teva Pharmaceuticals Industries Ltd.
7.22. Vitalograph Ltd.
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • 3M Co.
  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corp.
  • Adherium Ltd.
  • Air Liquide S.A.
  • AstraZeneca PLC
  • Bespak
  • Boehringer Ingelheim International GmbH
  • Chiesi Farmaceutici S.P.A.
  • Gilbert Technologies B.V.
  • GlaxoSmithKline PLC
  • H&T Presspart Manufacturing Ltd.
  • Hamilton Medical AG
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Novartis AG
  • PMD Device Solutions Ltd.
  • ResMed Corp.
  • Savara, Inc.
  • Teicos Pharma Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Vitalograph Ltd.
Note: Product cover images may vary from those shown